Home » AMEX » AMEX TRADED STOCKS » ACOR () AMEX Stocks : ACOR () on Investors NewsDesk Acorda Therapeutics Announces Delisting from Nasdaq Acorda Therapeutics Announces Nasdaq Delisting Notification Acorda files for bankruptcy, reveals asset sale plan Acorda Therapeutics and Merz Announce Signing of "Stalking Horse" Asset Purchase Agreement Acorda Cancels Q4 and Year End 2023 Earnings Conference Call Scheduled for April 1, 2024 Acorda Fourth Quarter/Year End 2023 Update: Webcast/Conference Call Scheduled for April 1, 2024 Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025 Acorda Therapeutics, Inc.'s (NASDAQ:ACOR) Shares Bounce 53% But Its Business Still Trails The Industry Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q3 2023 Earnings Call Transcript Acorda Therapeutics Reports Third Quarter 2023 Financial Results Acorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023 Acorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American Countries for Approval of INBRIJA® Acorda Therapeutics (ACOR): A Comprehensive Analysis of Its Market Value Acorda Therapeutics Reports Second Quarter 2023 Financial Results Acorda Therapeutics Announces Launch of New INBRIJA® Campaign: "For The Fighters™" Acorda Second Quarter 2023 Update: Webcast/Conference Call Scheduled for August 8, 2023 Tom Burns Elected to the Acorda Therapeutics Board of Directors Acorda Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement Little Excitement Around Acorda Therapeutics, Inc.'s (NASDAQ:ACOR) Revenues Acorda Therapeutics Announces Completion of 1-for-20 Reverse Stock Split Yahoo! Finance: ACOR News